
In early 2013, SynapDx, an early stage laboratory services company, started clinical trials of a new blood-based test to enable earlier detection of Autism Spectrum Disorders (ASDs). The test is reported to have an estimated 85% accuracy rate, attracting the interest of Google Ventures. This investment arm of the search giant partnered with SynapDx to… Read more »